Toggle Offcanvas
...
 
Estrogen Tenders

Estrogen Tenders

View Estrogen tenders, RFPs and contracts. Bid on readily available Estrogen tenders with the best and most comprehensive tendering platform, since 2002.
Estrogen is a group of hormones responsible for female sexual development and reproductive functions. It is used in various medical treatments, including birth control and hormone therapy for menopause.

Bidding for Estrogen tenders is extremely lucrative for companies of all sizes. Tendering authorities and private companies release thousands of contracts worth millions for procurement of Estrogen.

Global Tenders stands out as the largest platform dedicated to pharmaceutical tenders and government contracts. Boasting over 20 years of experience in the tender business, GlobalTenders offers the most extensive and reliable Tenders/RFPs/Contracts Database available. The platform aggregates contracts from both public and private sources, connecting with a vast network of over half a million buyers. Employing advanced artificial intelligence, our meticulous process involves gathering information from over a hundred thousand sources. The data is then intelligently categorized into thousands of subcategories for easy filtering and presenting it in a user-friendly format for quick comprehension.

In addition to tender information, we offer in-depth Estrogen market analysis, bid consultancy services, and insights into top bidders and winners.

Sign up now to get instant access to unlimited Estrogen tenders, advanced search filters, market analysis, industry trends, tender training and 24/7 customer support.

3 Live Notices for Estrogen Tenders

Showing 1 to 3

Supply Reagents And Laboratory Supplies
country Romania
posting date10 Oct 2025
deadline17 Nov 2025
Completion Of Non-Exclusive Discount Agreements According To Section 130A (8) Sgb V On The Active Ingredients Mentioned With A Final Option In The Context Of The So-Called Open House Process.
country Germany
posting date25 Jul 2025
deadline31 Dec 2026
Conclusion Of Non-Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8/130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Dienogest And Estrogen (G03Fa15) Within The Framework Of A So-Called Open-House Model.
country Germany
posting date14 Oct 2024
deadline30 Sep 2026

Share Share this page